Similarly, KIF23, as a key regulator of cytokinesis, is also found to be correlated with poor prognosis for patients with hepatocellular carcinoma (Sun et al., 2015), glioma (Sun et al., 2016), gastric cancer (Li et al., 2019), and non-small-cell lung cancer (Vikberg et al., 2017). This evidence concerns the gene KIF23 and glioma.